Astaxanthin Market  By Source (Natural, Synthetic) , By Form (Dry, Liquid) By Application (Dietary supplements, Cosmetics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Astaxanthin Market  By Source (Natural, Synthetic) , By Form (Dry, Liquid) By Application (Dietary supplements, Cosmetics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033


Astaxanthin Market
The astaxanthin market was valued at $0.8 billion in 2023 and is projected to reach $1.6 billion by 2033, growing at a CAGR of 8.1% from 2024 to 2033.
Astaxanthin is a red-colored pigment that belongs to the category of xanthophyll carotenoid and is present in several microorganisms and marine organisms. Astaxanthin is known for its antioxidant properties and aids in the protection of cells from free radicals. The compound is consumed in the form of supplements to enhance the health of brain, eyes, & skin; regulate high cholesterol levels; and support the immune system. Moreover, astaxanthin is used in the aquaculture industry to integrate pigmentation into farmed trout, salmons, and shrimps. This process elevates the appearance of aquaculture products and enhances their market value.
Increase in awareness regarding fit lifestyle and importance of health supplements is a significant driver of the astaxanthin market. In addition, astaxanthin is a natural product due to which it witnesses a high demand from the supplements and cosmetics industries, owing to surge in inclination toward organic or natural products. In the coming future, the trend of utilizing astaxanthin in crop production is anticipated to acquire notable traction. As per an article published by SpringerLink, a scientific portfolio, application of astaxanthin into rice seedlings eliminates their oxidative stress, regulates their homeostatic balance, and boosts their tolerance toward salinity.
However, the potential risk of side effects, such as disturbances in digestive system, due to high dosage of astaxanthin deters several individuals from its consumption and hampers the growth of the market. Furthermore, the extraction of astaxanthin from natural resources is gradually resulting in the depletion of microalgae and other marine organisms. This factor discourages the use of astaxanthin in diverse applications. Contrarily, to address the challenge of resource depletion, several microalgae-producing enterprises have been established across the globe to shift the production of astaxanthin into laboratories. As of September 2022, the European Commission identified 87 enterprises in 17 countries of Europe. These enterprises cultivate the astaxanthin-producing microalgae using photobioreactors. The extraction of astaxanthin from these cultured microalgae offers several benefits such as decreased environmental pollution, availability of scalability opportunities, and reduced exploitation of natural resources.

Segment Review

The astaxanthin market is divided into source, form, application, and region. On the basis of source, the market is bifurcated into natural and synthetic. As per form, it is divided into dry and liquid. Depending on application, it is classified into dietary supplements, cosmetics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of source, the natural segment dominated the market in 2023.
As per form, the dry segment acquired a high stake in the market in 2023.
Depending on application, the dietary supplements segment is projected to account for a high share of the market by 2033.
Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global astaxanthin market include INNOBIO Limited, Divis Laboratories Limited, Algaecan Biotech, ALGA Technologies, Cyanotech Corporation., Otsuka Pharmaceutical Co., Cardax, Fenchem, BGG, and Fuji Chemical Industries Company Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Key Market Segments

By Source

Natural
Synthetic

By Form

Dry
Liquid

By Application

Dietary supplements
Cosmetics
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
INNOBIO Limited
Divis Laboratories Limited
Algaecan Biotech
ALGA Technologies
Cyanotech Corporation.
Otsuka Pharmaceutical Co.
Cardax
Fenchem
BGG
Fuji Chemical Industries Company Limited


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ASTAXANTHIN  MARKET, BY SOURCE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Source
4.2. Natural
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Synthetic
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ASTAXANTHIN  MARKET, BY FORM
5.1. Market Overview
5.1.1 Market Size and Forecast, By Form
5.2. Dry
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Liquid
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: ASTAXANTHIN  MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Dietary Supplements
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Cosmetics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: ASTAXANTHIN  MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Source
7.2.3. Market Size and Forecast, By Form
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Astaxanthin  Market
7.2.6.1. Market Size and Forecast, By Source
7.2.6.2. Market Size and Forecast, By Form
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Astaxanthin  Market
7.2.7.1. Market Size and Forecast, By Source
7.2.7.2. Market Size and Forecast, By Form
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Astaxanthin  Market
7.2.8.1. Market Size and Forecast, By Source
7.2.8.2. Market Size and Forecast, By Form
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Source
7.3.3. Market Size and Forecast, By Form
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. France Astaxanthin  Market
7.3.6.1. Market Size and Forecast, By Source
7.3.6.2. Market Size and Forecast, By Form
7.3.6.3. Market Size and Forecast, By Application
7.3.7. Germany Astaxanthin  Market
7.3.7.1. Market Size and Forecast, By Source
7.3.7.2. Market Size and Forecast, By Form
7.3.7.3. Market Size and Forecast, By Application
7.3.8. Italy Astaxanthin  Market
7.3.8.1. Market Size and Forecast, By Source
7.3.8.2. Market Size and Forecast, By Form
7.3.8.3. Market Size and Forecast, By Application
7.3.9. Spain Astaxanthin  Market
7.3.9.1. Market Size and Forecast, By Source
7.3.9.2. Market Size and Forecast, By Form
7.3.9.3. Market Size and Forecast, By Application
7.3.10. UK Astaxanthin  Market
7.3.10.1. Market Size and Forecast, By Source
7.3.10.2. Market Size and Forecast, By Form
7.3.10.3. Market Size and Forecast, By Application
7.3.11. Rest Of Europe Astaxanthin  Market
7.3.11.1. Market Size and Forecast, By Source
7.3.11.2. Market Size and Forecast, By Form
7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Source
7.4.3. Market Size and Forecast, By Form
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. China Astaxanthin  Market
7.4.6.1. Market Size and Forecast, By Source
7.4.6.2. Market Size and Forecast, By Form
7.4.6.3. Market Size and Forecast, By Application
7.4.7. Japan Astaxanthin  Market
7.4.7.1. Market Size and Forecast, By Source
7.4.7.2. Market Size and Forecast, By Form
7.4.7.3. Market Size and Forecast, By Application
7.4.8. India Astaxanthin  Market
7.4.8.1. Market Size and Forecast, By Source
7.4.8.2. Market Size and Forecast, By Form
7.4.8.3. Market Size and Forecast, By Application
7.4.9. South Korea Astaxanthin  Market
7.4.9.1. Market Size and Forecast, By Source
7.4.9.2. Market Size and Forecast, By Form
7.4.9.3. Market Size and Forecast, By Application
7.4.10. Australia Astaxanthin  Market
7.4.10.1. Market Size and Forecast, By Source
7.4.10.2. Market Size and Forecast, By Form
7.4.10.3. Market Size and Forecast, By Application
7.4.11. Rest of Asia-Pacific Astaxanthin  Market
7.4.11.1. Market Size and Forecast, By Source
7.4.11.2. Market Size and Forecast, By Form
7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Source
7.5.3. Market Size and Forecast, By Form
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Astaxanthin  Market
7.5.6.1. Market Size and Forecast, By Source
7.5.6.2. Market Size and Forecast, By Form
7.5.6.3. Market Size and Forecast, By Application
7.5.7. South Africa Astaxanthin  Market
7.5.7.1. Market Size and Forecast, By Source
7.5.7.2. Market Size and Forecast, By Form
7.5.7.3. Market Size and Forecast, By Application
7.5.8. Saudi Arabia Astaxanthin  Market
7.5.8.1. Market Size and Forecast, By Source
7.5.8.2. Market Size and Forecast, By Form
7.5.8.3. Market Size and Forecast, By Application
7.5.9. Rest of LAMEA Astaxanthin  Market
7.5.9.1. Market Size and Forecast, By Source
7.5.9.2. Market Size and Forecast, By Form
7.5.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. INNOBIO Limited
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Divis Laboratories Limited
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Algaecan Biotech
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. ALGA Technologies
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Cyanotech Corporation.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Otsuka Pharmaceutical Co.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Cardax
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Fenchem
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. BGG
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Fuji Chemical Industries Company Limited
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 2. ASTAXANTHIN  MARKET FOR NATURAL, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ASTAXANTHIN  MARKET FOR SYNTHETIC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 5. ASTAXANTHIN  MARKET FOR DRY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ASTAXANTHIN  MARKET FOR LIQUID, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 8. ASTAXANTHIN  MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. ASTAXANTHIN  MARKET FOR COSMETICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. ASTAXANTHIN  MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ASTAXANTHIN  MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA ASTAXANTHIN  MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. U.S. ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 17. U.S. ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. CANADA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 20. CANADA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 21. CANADA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. MEXICO ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. EUROPE ASTAXANTHIN  MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. FRANCE ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 30. FRANCE ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 31. FRANCE ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 33. GERMANY ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 34. GERMANY ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. ITALY ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 36. ITALY ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 37. ITALY ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. SPAIN ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 39. SPAIN ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 40. SPAIN ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. UK ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 42. UK ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 43. UK ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. REST OF EUROPE ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. ASIA-PACIFIC ASTAXANTHIN  MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. CHINA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 52. CHINA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 53. CHINA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 55. JAPAN ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 56. JAPAN ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. INDIA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 58. INDIA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 59. INDIA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. SOUTH KOREA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 61. SOUTH KOREA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 62. SOUTH KOREA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 64. AUSTRALIA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 65. AUSTRALIA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. REST OF ASIA-PACIFIC ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. LAMEA ASTAXANTHIN  MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 73. BRAZIL ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. SOUTH AFRICA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 77. SOUTH AFRICA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 78. SOUTH AFRICA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 80. SAUDI ARABIA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 81. SAUDI ARABIA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. REST OF LAMEA ASTAXANTHIN  MARKET, BY SOURCE, 2024 - 2033 ($BILLION)
TABLE 83. REST OF LAMEA ASTAXANTHIN  MARKET, BY FORM, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA ASTAXANTHIN  MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. INNOBIO LIMITED: KEY EXECUTIVES
TABLE 86. INNOBIO LIMITED: COMPANY SNAPSHOT
TABLE 87. INNOBIO LIMITED: OPERATING SEGMENTS
TABLE 88. INNOBIO LIMITED: PRODUCT PORTFOLIO
TABLE 89. INNOBIO LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. DIVIS LABORATORIES LIMITED: KEY EXECUTIVES
TABLE 91. DIVIS LABORATORIES LIMITED: COMPANY SNAPSHOT
TABLE 92. DIVIS LABORATORIES LIMITED: OPERATING SEGMENTS
TABLE 93. DIVIS LABORATORIES LIMITED: PRODUCT PORTFOLIO
TABLE 94. DIVIS LABORATORIES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. ALGAECAN BIOTECH: KEY EXECUTIVES
TABLE 96. ALGAECAN BIOTECH: COMPANY SNAPSHOT
TABLE 97. ALGAECAN BIOTECH: OPERATING SEGMENTS
TABLE 98. ALGAECAN BIOTECH: PRODUCT PORTFOLIO
TABLE 99. ALGAECAN BIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. ALGA TECHNOLOGIES: KEY EXECUTIVES
TABLE 101. ALGA TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 102. ALGA TECHNOLOGIES: OPERATING SEGMENTS
TABLE 103. ALGA TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 104. ALGA TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. CYANOTECH CORPORATION.: KEY EXECUTIVES
TABLE 106. CYANOTECH CORPORATION.: COMPANY SNAPSHOT
TABLE 107. CYANOTECH CORPORATION.: OPERATING SEGMENTS
TABLE 108. CYANOTECH CORPORATION.: PRODUCT PORTFOLIO
TABLE 109. CYANOTECH CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. OTSUKA PHARMACEUTICAL CO.: KEY EXECUTIVES
TABLE 111. OTSUKA PHARMACEUTICAL CO.: COMPANY SNAPSHOT
TABLE 112. OTSUKA PHARMACEUTICAL CO.: OPERATING SEGMENTS
TABLE 113. OTSUKA PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 114. OTSUKA PHARMACEUTICAL CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. CARDAX: KEY EXECUTIVES
TABLE 116. CARDAX: COMPANY SNAPSHOT
TABLE 117. CARDAX: OPERATING SEGMENTS
TABLE 118. CARDAX: PRODUCT PORTFOLIO
TABLE 119. CARDAX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. FENCHEM: KEY EXECUTIVES
TABLE 121. FENCHEM: COMPANY SNAPSHOT
TABLE 122. FENCHEM: OPERATING SEGMENTS
TABLE 123. FENCHEM: PRODUCT PORTFOLIO
TABLE 124. FENCHEM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. BGG: KEY EXECUTIVES
TABLE 126. BGG: COMPANY SNAPSHOT
TABLE 127. BGG: OPERATING SEGMENTS
TABLE 128. BGG: PRODUCT PORTFOLIO
TABLE 129. BGG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: KEY EXECUTIVES
TABLE 131. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 132. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: OPERATING SEGMENTS
TABLE 133. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: PRODUCT PORTFOLIO
TABLE 134. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ASTAXANTHIN  MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ASTAXANTHIN  MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ASTAXANTHIN  MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALASTAXANTHIN  MARKET
FIGURE 10. GLOBAL ASTAXANTHIN  MARKET SEGMENTATION, BY SOURCE
FIGURE 11. ASTAXANTHIN  MARKET FOR NATURAL, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ASTAXANTHIN  MARKET FOR SYNTHETIC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ASTAXANTHIN  MARKET SEGMENTATION, BY FORM
FIGURE 14. ASTAXANTHIN  MARKET FOR DRY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ASTAXANTHIN  MARKET FOR LIQUID, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GLOBAL ASTAXANTHIN  MARKET SEGMENTATION, BY APPLICATION
FIGURE 17. ASTAXANTHIN  MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. ASTAXANTHIN  MARKET FOR COSMETICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. ASTAXANTHIN  MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 24. COMPETITIVE DASHBOARD
FIGURE 25. COMPETITIVE HEATMAP: ASTAXANTHIN  MARKET
FIGURE 26. TOP PLAYER POSITIONING, 2023
FIGURE 27. INNOBIO LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. INNOBIO LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. INNOBIO LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. DIVIS LABORATORIES LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. DIVIS LABORATORIES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. DIVIS LABORATORIES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. ALGAECAN BIOTECH: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. ALGAECAN BIOTECH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. ALGAECAN BIOTECH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. ALGA TECHNOLOGIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. ALGA TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. ALGA TECHNOLOGIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. CYANOTECH CORPORATION.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. CYANOTECH CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. CYANOTECH CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. OTSUKA PHARMACEUTICAL CO.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. OTSUKA PHARMACEUTICAL CO.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. CARDAX: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. CARDAX: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. CARDAX: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. FENCHEM: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. FENCHEM: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. FENCHEM: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. BGG: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. BGG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. BGG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. FUJI CHEMICAL INDUSTRIES COMPANY LIMITED: REVENUE SHARE, BY REGION, 2023 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings